CHYM · Chime Financial, Inc. · Stock research

Current Thesis

The re-rate that began with the 2026-08-05 Q2 print is intact and the operating case has stopped being the open question. Revenue $669.8M against $640.4M consensus, +27% YoY versus +25% in Q1; EPS $0.07 against a $(0.00) estimate; GAAP net income $28M, the second profitable quarter in a row; FY2026 revenue guidance lifted to $2.725–2.745B from $2.66–2.69B, the second raise inside one quarter. The shares rose roughly 28.5% on 2026-08-06 (GuruFocus) and closed $32.78 on 2026-08-21, 0.9% under the $33.07 52-week high, with a three-month price change of +84.2% and RSI(14) at 75.4.

What changed since the 2026-08-15 note is the supply side. DST Global Advisors, a 10% owner, sold 1,041,325 Class A shares on 2026-08-11 and 08-12 at weighted-average prices of $32.1064 and $32.0086, then 4,809,969 shares on 2026-08-18 and 08-19 at weighted averages of $32.2128 to $33.1139 (roughly $156.9M across a $32.00–$33.38 range), disclosed in a Form 4 filed 2026-08-20. The narrative leg on offer is multiple repair on a 20%-plus grower that now prints profit; the near-term question is whether marginal demand absorbs a large holder unwinding at the highs with no company event scheduled for roughly ten weeks.

Bullish and bearish views on Chime Financial, Inc.

The model's bull view on Chime Financial, Inc. (CHYM), in brief: Growth accelerated into the print. Q2 2026 (2026-08-05): revenue $669.8M, +27% YoY, up from +25% in Q1 (2026-05-06). Purchase volume $38B, +17% YoY, or $39.4B including outbound instant transfers. Profit repeated. GAAP net income $28M in Q2 after $53M in Q1; adjusted EBITDA… The bear view: The largest disclosed seller is selling at the highs. Both cases follow in full.

Bull Case

• Growth accelerated into the print. Q2 2026 (2026-08-05): revenue $669.8M, +27% YoY, up from +25% in Q1 (2026-05-06). Purchase volume $38B, +17% YoY, or $39.4B including outbound instant transfers.
• Profit repeated. GAAP net income $28M in Q2 after $53M in Q1; adjusted EBITDA $102M at a 15% margin, more than 12pp above the year-ago level. FY2026 adjusted EBITDA guided $465–475M.
• Guidance raised twice in one quarter. FY revenue $2.66–2.69B on 2026-05-06 became $2.725–2.745B on 2026-08-05, against $2.682B consensus; Q3 revenue guided $680–690M versus $668.1M estimated, Q3 adjusted EBITDA $105–110M.
• Member adds at a company record pace. 10.4M active members, +20% YoY, with 1.7M net adds over the trailing twelve months, described by the company as the most in any consecutive 12-month period in its history.
• Cost base cut before the print. The board approved a restructuring on 2026-07-31 removing about 10% of the workforce, with $16–20M of net cash charges and $9–12M of stock-based-compensation reduction.
• Sell-side marks kept moving after the initial repricing. Ten target raises between 2026-08-06 and 2026-08-11 (Canaccord $45, B. Riley $37, Piper Sandler $35, KBW $35, Goldman $33, Morgan Stanley $33, BMO $32, UBS $28 at Neutral, Barclays $33 on 08-07, Evercore ISI $39 on 08-11), then a second Morgan Stanley raise to $39 on 2026-08-18.
• Balance sheet is unlevered against the restructuring. $536M cash and equivalents plus $527M marketable securities at Q2 quarter-end (Q2 2026 10-Q).

Bear Case

• The largest disclosed seller is selling at the highs. Two Form 4-disclosed blocks — After the second block the seven DST filing entities still report holdings, the largest being DST Global VI, L.P.
• Margin gave back three points sequentially. Adjusted EBITDA $102M / 15% in Q2 against $119M / 18% in Q1; GAAP net income $28M against $53M. Revenue accelerated while profitability moved the other way.
• Monetization per member slipped. ARPAM $260 in Q2 versus $263 in Q1, +6% YoY. Q2's revenue growth came predominantly from member adds.
• The finance seat is interim. Matt Newcomb stepped down as CFO effective 2026-08-07; Mark Troughton holds President and interim CFO, carrying a twice-raised guide without a permanent appointment reported through 2026-08-21.
• A second institutional reduction is on record. Tiger Global's 13F disclosed 2026-08-14 shows a 52% cut to 5,284,045 shares as of the June quarter-end, which predates the August move.
• Price now sits at or through most published targets. The 2026-08-21 close of $32.78 is above BMO's $32 and UBS's Neutral $28 and level with the $33 cluster from Goldman, Barclays and Morgan Stanley's first mark; only Canaccord $45, Evercore $39 and Morgan Stanley's 08-18 $39 sit materially higher.
• Overhead supply from the IPO window is untouched. The $37.11 first-day close and $38.67 listed-history high on the adjusted series remain above the current 52-week high of $33.07.
• Interchange dependency is structural. Revenue routes through partner banks below $10B in assets that retain the Durbin small-issuer exemption; a Reg II change hits the unit economics directly.

Setup & Price Structure

• Reference levels. Last completed daily close $32.78 (2026-08-21); 52-week high $33.07; distance from that high -0.9%; RSI(14) 75.4; three-month price change +84.2%.
• Momentum is cooling while price holds. The 2026-08-14 close was $32.02 with RSI(14) at 83.8. Price is higher two weeks later and the oscillator is roughly eight points lower — measured divergence, not yet a break.
• A tight shelf has formed since 2026-08-11. The Form 4 execution ranges from 08-11 through 08-19 span $32.00 to $33.38, a band of roughly 4% across six sessions during which the tape absorbed both insider blocks. That shelf, and the 2026-08-06 gap beneath it, are the structure a pullback would test.
• The narrative is maturing. The narrative is well known and still working — thirteen-plus covering analysts, ten target raises in the 2026-08-06 to 08-11 window, price within 1% of the 52-week high on 2026-08-21 — while incremental flow moderates: RSI down from 83.8 to 75.4, only one new target raise (Morgan Stanley, 2026-08-18) in the ten days after 08-11, and no scheduled company event until quarter-end. It flips to saturated if further 10%-owner Form 4 sales print while the $33.07 high goes unbroken and no new marks arrive.
• Crowding/positioning observables, stated as observables: RSI(14) 75.4 within 0.9% of the 52-week high; two Form 4 sale blocks by a 10% owner in six sessions; a 52% 13F reduction by Tiger Global disclosed 2026-08-14; sell-side targets clustered at or below spot with the highest at $45; no earnings date inside 30 days, so no imminent print is compressing positioning.

Catalyst Calendar (next 30 days)

• No scheduled company event falls between 2026-08-23 and 2026-09-22. The window is empty of prints, guidance updates or confirmed conference appearances.
• Ongoing, event-driven: any further DST Global sale is reportable on Form 4 within two business days of the transaction, so distribution — if it continues — becomes public on a two-day lag rather than at a quarterly 13F date.
• 2026-09-30 — Q3 2026 quarter-end. The $16–20M restructuring charge from the 2026-07-31 plan lands in this quarter.
• ~2026-11-03 (est.) — Q3 2026 results. Q1 reported 2026-05-06 and Q2 on 2026-08-05; the first read on whether the 10% headcount cut converts into margin against the $105–110M Q3 adjusted-EBITDA guide.
• 2026-11-16 — Q3 13F deadline. Shows whether Tiger Global's reduction continued through September and whether new institutional holders stepped in during the re-rate.

What Would Change Our Mind

The structure at risk is the $32.00–$33.38 shelf built between 2026-08-11 and 2026-08-19, and the 2026-08-06 gap immediately below it. Losing both would say the August bid was the sell-side re-marking plus print-driven flow, and that it did not survive a 10% owner distributing into it. A weekly close below $30 is the gradeable break; it puts price back inside the gap with no company event to arrest the move before the ~November print.

On the fundamentals, three datapoints would flip the read independently of price: a third consecutive sequential ARPAM decline below the $260 reported for Q2; Q3 adjusted EBITDA landing at or under the $105–110M guide with margin still at or below 15%, which would say the 10% headcount cut did not reach the operating line; and any downward revision to the $2.725–2.745B FY revenue guide issued from the interim CFO seat. On the other side, a weekly close above $33.07 on expanding volume with no fresh Form 4 supply would argue the shelf is accumulation rather than distribution.

Correlation Notes

• Consumer-fintech interchange complex. The revenue model depends on debit interchange through partner banks under the sub-$10B-asset Durbin exemption, so headline risk is shared with other neobank and prepaid-adjacent issuers; a Federal Reserve proposal or bill text naming the small-issuer carve-out would move the group together rather than this name alone.
• Consumer spending data. Purchase volume of $38B in Q2 (+17% YoY) ties the top line to card spend among the company's lower-to-middle-income member base, which makes labor-market prints a second-order input to the growth line.
• 2025 IPO cohort supply dynamics. The name lists from a June 2025 IPO at $27, and its August tape has been set by holder distribution rather than by index or macro flow; peers from the same listing window carry the same venture-holder unwind mechanic, which shows up as Form 4 and 13F events rather than as news.
• High-multiple growth beta. The 2026-08-06 session in which the shares rose about 28.5% came on a day the S&P 500 and Dow fell with Brent up 4%, so the print, not the index, drove it; absent a company event, correlation to the broader growth complex reasserts.